Mårild Karl, Lerchova Tereza, Östensson Malin, Imberg Henrik, Størdal Ketil, Ludvigsson Johnny
Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Pediatric Gastroenterology Unit, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
Aliment Pharmacol Ther. 2025 Jan;61(2):323-334. doi: 10.1111/apt.18358. Epub 2024 Oct 25.
Childhood antibiotic use has been associated with inflammatory bowel disease (IBD), although the potential contribution of infection frequency remains uncertain.
To explore the association between early-life infections, antibiotics and IBD development.
We used population-based data from ABIS (Sweden) and MoBa (Norway) cohorts following children from birth (1997-2009) until 2021. Prospectively collected questionnaires identified infection frequency (any, gastrointestinal and respiratory) and antibiotics (any, penicillin and non-penicillin) until age 3. IBD diagnosis required ≥ 2 records in national health registries. Cohort-specific hazard ratios (aHR), adjusted for parental education, smoking and IBD were estimated and pooled using a random-effects model. Antibiotic analyses were adjusted for infection frequency.
There were 103,046 children (11,872 ABIS and 91,174 MoBa), contributing to 1,663,898 person-years of follow-up, during which 395 were diagnosed with IBD. The frequency of any infection at 0 to < 1 and 1 to < 3 years showed a pooled aHR of 1.01 (95% confidence interval [CI] = 0.96-1.07) and 1.00 (95% CI = 0.99-1.01) per additional infection for IBD. Adjusting for infections, any versus no antibiotics in the first year was associated with IBD (pooled aHR = 1.33 [95% CI = 1.01-1.76]). The aHR for additional antibiotic course was 1.17 (95% CI = 0.96-1.44), driven by penicillin (per additional course, aHR = 1.28 [95% CI = 1.02-1.60]). Although antibiotics at 1 to < 3 years did not show an association with IBD or Crohn's disease, non-penicillin antibiotics were associated with ulcerative colitis (per additional course, aHR = 1.95 [95% CI = 1.38-2.75]).
Early-life antibiotic use was, a significant risk factor for childhood and early adult-onset IBD, independent of infection frequency.
儿童期使用抗生素与炎症性肠病(IBD)有关,尽管感染频率的潜在影响仍不确定。
探讨生命早期感染、抗生素与IBD发病之间的关联。
我们使用了来自ABIS(瑞典)和MoBa(挪威)队列的基于人群的数据,这些队列追踪了从出生(1997 - 2009年)到2021年的儿童。前瞻性收集的问卷确定了3岁前的感染频率(任何感染、胃肠道感染和呼吸道感染)以及抗生素使用情况(任何抗生素、青霉素和非青霉素类抗生素)。IBD诊断需要在国家卫生登记处有≥2条记录。估计并使用随机效应模型汇总了特定队列的风险比(aHR),并对父母教育程度、吸烟情况和IBD进行了调整。抗生素分析对感染频率进行了调整。
共有103,046名儿童(11,872名来自ABIS,91,174名来自MoBa),随访总人年数为1,663,898人年,在此期间395人被诊断为IBD。0至<1岁和1至<3岁时任何感染的频率显示,每增加一次感染,IBD的合并aHR为1.01(95%置信区间[CI]=0.96 - 1.07)和1.00(95%CI = 0.99 - 1.01)。在对感染进行调整后,第一年使用任何抗生素与未使用抗生素相比与IBD相关(合并aHR = 1.33 [95%CI = 1.01 - 1.76])。额外抗生素疗程的aHR为1.17(95%CI = 0.96 - 1.44),主要由青霉素驱动(每增加一个疗程,aHR = 1.28 [95%CI = 1.02 - 1.